Analytical Data
-
基因名
KAAG1
- Application
-
别名
KAAG1; RU2AS
-
种属
Human
-
表达系统
E. coli
-
标签
C-6*His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UBP8
-
表达区间
M1-K84
-
蛋白长度
Full Length
-
分子量
15.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
KAAG1, a member of the Kallikrein family, has garnered significant attention in recent years due to its potential implications in various biological processes and disease mechanisms. Initially identified as an important player in the regulation of extracellular matrix components, KAAG1's expression is notably altered in conditions such as cancer, inflammation, and cardiovascular diseases. The protein's interaction with serine proteases and its role in proteolytic pathways suggest that it may contribute to tumor progression and metastasis, making it a potential biomarker and therapeutic target. Researchers have focused on the recombinant production of KAAG1 to facilitate detailed studies of its structure, function, and interactions. The development of recombinant KAAG1 protein allows for the elucidation of its biochemical properties and the investigation of its role in cell signaling, providing insights into its potential as a target for drug development. Furthermore, understanding the mechanisms by which KAAG1 influences cellular processes could lead to novel therapeutic strategies for diseases associated with dysregulated expression of this protein. As the scientific community continues to explore the multifaceted roles of KAAG1, its recombinant form serves as a vital tool in deciphering the complexities of its biological functions and therapeutic applications.
